Peripheral Absolute Lymphocyte Count, Breast Cancer-Specific and Overall Mortality According to Race, Ethnicity, and Breast Cancer Subtypes.

Authors

Candice N Thompson, Ingrid Luo, Mina Satoyoshi, Pragati Kenkare, Gunita Kashyap, Holden T Maecker, Lidia Schapira, Esther M John, Scarlett Lin Gomez, Su-Ying Liang, Summer S Han, Allison W Kurian

Published in

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Aug 14, 2026. Epub Aug 14, 2026.

Abstract

Low absolute lymphocyte count (ALC) is associated with breast cancer-specific mortality (BCM) and overall mortality (OM) in non-Hispanic (NH) White women with triple-negative breast cancer (TNBC). However, little is known about the relationship of ALC with BCM or OM in other breast cancer subtypes, racial or ethnic groups. Here, we investigated the association of ALC with BCM and OM by breast cancer subtype and evaluated for modification by race or ethnicity.
We used the Oncoshare database, linking data from electronic medical records of academic and community institutions to data from the California Cancer Registry, to identify women diagnosed with stage I-III breast cancer in 2000-2017 who had a post-diagnosis ALC within five years. We used logistic regression to identify factors associated with low ALC(<1 K/µL) and Cox models to evaluate the association of minimum ALC (minALC) post-diagnosis with BCM and OM.
In 11,669 women, low ALC was associated with neutropenia, chemotherapy receipt, advanced stage, more comorbidities, and aggressive tumor features (all p≤0.001). Lower minALC was associated with higher OM(HR=0.96 per 1 K/µL increase, 95% CI 0.93-0.99), most strongly in TNBC(HR=0.73, 0.59-0.91). Race and ethnicity modified associations of minALC with BCM and OM (interaction p<0.001), more strongly in NH Black and Hispanic than NH White women.
Low peripheral ALC was associated with higher OM in women with estrogen and/or progesterone receptor-positive, HER2-negative breast cancer or TNBC.
Low ALC is more strongly associated with OM and BCM in women from minoritized racial and ethnic groups.

PMID:
42599159
Bibliographic data and abstract were imported from PubMed on 14 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.